These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31293267)

  • 1. The postoperatıve effects of use of trimetazidine before the coronary artery bypass graft surgery.
    Aksun M; Aksun S; Kestelli M; Kuru V; Tanyeli HF; Girgin S; Damar E; Golboyu BE; Karahan N
    Niger J Clin Pract; 2019 Jul; 22(7):997-1001. PubMed ID: 31293267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting.
    Tünerir B; Colak O; Alataş O; Beşoğul Y; Kural T; Aslan R
    Ann Thorac Surg; 1999 Dec; 68(6):2173-6. PubMed ID: 10616997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis.
    Zhang N; Lei J; Liu Q; Huang W; Xiao H; Lei H
    Cardiology; 2015; 131(2):86-96. PubMed ID: 25871315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting.
    Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Bottino F; Carvalho KG; Valência A
    Arq Bras Cardiol; 2011 Sep; 97(3):209-16. PubMed ID: 21808851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there any benefit of preoperative oral trimetazidine in coronary artery bypass graft?
    Sher-i-Murtaza M; Zubair M; Jalal A
    J Pak Med Assoc; 2012 Dec; 62(12):1271-6. PubMed ID: 23866471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection during coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study with trimetazidine.
    Vedrinne JM; Vedrinne C; Bompard D; Lehot JJ; Boissel JP; Champsaur G
    Anesth Analg; 1996 Apr; 82(4):712-8. PubMed ID: 8615485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
    Lopatin IuM; Dronova EP
    Kardiologiia; 2009; 49(2):15-21. PubMed ID: 19254211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimetazidine may protect the myocardium during cardiac surgery.
    Iskesen I; Kurdal AT; Eserdag M; Cerrahoglu M; Sirin BH
    Heart Surg Forum; 2009 Jun; 12(3):E175-9. PubMed ID: 19546072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Temizturk Z; Azboy D; Uysal A
    Heart Surg Forum; 2021 Jan; 24(1):E038-E047. PubMed ID: 33635267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effect of trimetazidine during coronary artery graft surgery.
    Fabiani JN; Ponzio O; Emerit I; Massonet-Castel S; Paris M; Chevalier P; Jebara V; Carpentier A
    J Cardiovasc Surg (Torino); 1992; 33(4):486-91. PubMed ID: 1527157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Wang C; Chen W; Yu M; Yang P
    Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.
    Birand A; Kudaiberdieva GZ; Batyraliev TA; Akgul F; Usal A
    Angiology; 1997 May; 48(5):413-22. PubMed ID: 9158385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial natriuretic peptide as an indicator of mild postoperative cardiac dysfunction after uncomplicated bypass surgery].
    Langenbach MR; Korbmacher B; Schulte H; Zirngibl H; Grabensee B; Plum J
    Z Kardiol; 2000 Dec; 89(12):1133-40. PubMed ID: 11201029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetazidine reduces oxidative stress in cardiac surgery.
    Iskesen I; Saribulbul O; Cerrahoglu M; Var A; Nazli Y; Sirin H
    Circ J; 2006 Sep; 70(9):1169-73. PubMed ID: 16936431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
    Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimetazidine and inflammatory response in coronary artery bypass grafting.
    Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Vieira FB; Valência A; Carvalho KG; Jessen B
    Arq Bras Cardiol; 2012 Aug; 99(2):688-96. PubMed ID: 22790403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.